Skip to main content
Top
Published in: Cancer Causes & Control 10/2012

01-10-2012 | Erratum

Erratum to: An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome

Authors: Gabriella M. Anic, Reid C. Thompson, L. Burton Nabors, Jeffrey J. Olson, James E. Browning, Melissa H. Madden, F. Reed Murtagh, Peter A. Forsyth, Kathleen M. Egan

Published in: Cancer Causes & Control | Issue 10/2012

Login to get access

Excerpt

Unfortunately, given name and family name of two authors (Nabors LB and F. Reed Murtagh) have been wrongly identified in the original article. The correct representation has been provided in this erratum. …
Metadata
Title
Erratum to: An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome
Authors
Gabriella M. Anic
Reid C. Thompson
L. Burton Nabors
Jeffrey J. Olson
James E. Browning
Melissa H. Madden
F. Reed Murtagh
Peter A. Forsyth
Kathleen M. Egan
Publication date
01-10-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 10/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0044-5

Other articles of this Issue 10/2012

Cancer Causes & Control 10/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine